#United States #New York #Wolf Haldenstein #SEC #POMDOCTOR

Class Action Lawsuit Against PomDoctor, Ltd.

Wolf Haldenstein Adler Freeman & Herz LLP has announced the filing of a class action lawsuit against PomDoctor, Ltd. (NASDAQ: POM) concerning the American Depositary Receipts (ADRs) of the company. The legal action is aimed at those who acquired PomDoctor ADRs between October 9, 2025, and December 11, 2025. Investors involved in this period are encouraged to seek appointment as lead plaintiff before the deadline on April 6, 2026.

The complaint accuses PomDoctor of multiple misleading actions, including:
1. Engagement in a fraudulent stock promotion scheme that relied on misinformation circulated via social media platforms.
2. Facilitating stock dumps by insiders or affiliated parties through offshore or nominee accounts during a manipulated price inflation campaign.
3. Omitting critical information about the false rumors and artificial trading activities that inflated the stock price from their public disclosures.

As a result of these allegations, investors faced significant losses when the truth behind the company’s valuation began to surface. The lawsuit seeks to hold the responsible parties accountable for their actions that misled investors and violated securities laws.

About Wolf Haldenstein

Founded in 1888, Wolf Haldenstein has a long-standing reputation for representing investors who have suffered financial losses due to deceptive practices in the market. With over 125 years of experience in securities litigation, the firm is well-equipped to advocate on behalf of investors who have faced financial harm. Their commitment to justice in the realm of investor protection stands as a hallmark of their operations.

The legal team at Wolf Haldenstein is encouraging any affected investors or those with pertinent information to come forward. Those interested can reach out to the firm through various means, including phone calls at (800) 575-0735 or (212) 545-4774, or via email at [email protected]. Gregory Stone serves as the Director of Case and Financial Analysis and can also be contacted for inquiries.

This press release should be viewed as Attorney Advertising, as per the laws and ethical requirements in certain jurisdictions. Wolf Haldenstein remains committed to advocating for the rights and interests of investors during these challenging times. Therefore, any investors who feel they may have been impacted by PomDoctor's alleged malpractice are urged to consider joining the legal action and submitting their contact information promptly.

For more details on joining this case or further information about the lawsuit, please visit the Wolf Haldenstein website.